They used siRNAs to specifically inhibit expression of FMOD and ROR1 in human fibroblast cell lines, healthy B cells and CLL cells Their results indicated that utilization of siRNA is able to induce a specific decreasing (75–95%) in ROR1 and FMOD expression at mRNA levels. The gene discussed is FMOD; the disease is B-cell chronic lymphocytic leukemia.